HB87 would amend Virginia’s Medicaid state plan statute, § 32.1-325, to add and update a wide range of required and authorized medical assistance benefits and administrative rules. The bill is broad in scope and touches maternal health, telehealth, cancer screening and treatment, pediatric services, durable medical equipment, transplant coverage, behavioral health, and other Medicaid-covered services. It also adds specific requirements for patient-initiated and provider-to-provider consultations, including telemedicine-based consultations, and expands reimbursement rules for certain remote services.
A major portion of the bill focuses on coverage mandates and clarifications for services that DMAS must include in the state plan, such as postpartum care, family planning, breast and cervical cancer treatment, mammograms, pap smears, prostate and colorectal cancer screening, hearing screenings, dental care for pregnant women, postpartum doula care, remote patient monitoring, remote ultrasound and fetal non-stress tests, rapid whole genome sequencing for young children in intensive care, and treatment for PANS/PANDAS. It also addresses coverage for telemedicine, including audio-only services in some settings, and removes barriers for telemedicine-only providers by prohibiting proprietary technology requirements and, in some cases, in-state physical presence or service address requirements.
The bill would also affect Medicaid administration and provider participation. It requires the Department of Medical Assistance Services to incorporate certain fiscal-impact review practices, maintain provider contracting and appeal procedures, reimburse specified licensed mental health professionals and pharmacists for covered services, and continue or expand special provisions for children, foster care populations, long-term care partnerships, and medically needy eligibility rules. In practical terms, the bill would broaden the set of services and provider types eligible for Medicaid reimbursement and would direct DMAS to update its state plan and regulations accordingly.
The general sentiment reflected in the available context appears neutral to favorable, but limited. There were no recorded committee transcripts or roll-call votes, and the bill was ultimately incorporated into HB1284 by the House Health and Human Services Committee by voice vote. That procedural outcome suggests the bill’s substance was accepted in committee, though the available record does not show detailed debate or opposition.
The main points of contention likely center on cost, scope, and policy priorities. Because the bill adds many new or expanded Medicaid benefits, potential concerns include fiscal impact on the Commonwealth and local systems, administrative complexity, and whether all of the covered services are sufficiently evidence-based or should be mandated in statute. Telehealth provisions, especially audio-only coverage and reduced provider-location requirements, may also raise questions about oversight and reimbursement standards. No specific opposition is documented in the provided materials, but those are the most likely areas of debate.
HB87 would substantially expand and refine the statutory requirements governing Virginia’s Medicaid state plan under § 32.1-325. It would require DMAS to cover or facilitate reimbursement for a broad set of services, including telemedicine, remote monitoring, maternal and postpartum care, cancer screening and treatment, pediatric genetic testing, dental services for pregnant women, postpartum doula care, and certain specialty consultations. It also updates provider enrollment, contracting, and appeal rules, and it directs the agency to implement related regulations and reporting obligations. The bill would therefore affect Medicaid beneficiaries, providers, managed care contractors, school-based health services, telehealth vendors, and DMAS administration.
The available record suggests the bill was received favorably enough to be incorporated into another measure by the House Health and Human Services Committee via voice vote. Because there are no committee transcripts or recorded votes showing debate, the overall sentiment cannot be measured precisely, but the procedural history indicates at least some institutional support for the bill’s Medicaid and telehealth provisions. No explicit opposition is documented in the provided context.
The most likely areas of contention are the bill’s fiscal impact and the breadth of mandated Medicaid coverage. Opponents could question whether the Commonwealth should statutorily require coverage for numerous specialized services, some of which are newer, less common, or more controversial in medical policy debates, such as PANS/PANDAS treatment, remote fetal monitoring, postpartum doula care, and expanded telehealth reimbursement. There may also be concern about administrative burden on DMAS and local agencies, as well as whether the bill’s provider and technology rules could complicate oversight or reimbursement. No specific individuals or groups are identified in the record as opposing these provisions, but those policy issues are the most plausible points of contention.